A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

[1]  Xun Xu,et al.  Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment , 2017, Nature Communications.

[2]  A. Bullock,et al.  Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. , 2017, The New England journal of medicine.

[3]  Yichong Li,et al.  Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 , 2017, JAMA.

[4]  P. Fu,et al.  Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial , 2017, JAMA.

[5]  G. Hu,et al.  Diabetes: Leveraging the Tipping Point of the Diabetes Pandemic , 2017, Diabetes.

[6]  S. Saydah,et al.  Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012 , 2017, The New England journal of medicine.

[7]  T. Lancet.  Ageing in China: a ticking bomb , 2016, The Lancet.

[8]  Xiyan Zhao,et al.  Growing Trend of China's Contribution to Global Diabetes Research , 2016, Medicine.

[9]  M. M. Rahman,et al.  Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .

[10]  Richard van Noorden.  China by the numbers. , 2016, Nature.

[11]  J. Woo,et al.  Short‐term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps , 2015, Diabetes/Metabolism Research Reviews.

[12]  Laurie Quinn,et al.  Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. , 2015, Circulation.

[13]  P. van Endert,et al.  Pancreatic β-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota. , 2015, Immunity.

[14]  G. Bray,et al.  Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association , 2015, Diabetes Care.

[15]  Cunchuan Wang,et al.  Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m2 , 2015, BMC Surgery.

[16]  Y. Bao,et al.  Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, con , 2015, The lancet. Diabetes & endocrinology.

[17]  Xilin Yang,et al.  Prevalence of Gestational Diabetes Mellitus and Its Risk Factors in Chinese Pregnant Women: A Prospective Population-Based Study in Tianjin, China , 2015, PloS one.

[18]  Xinli Hu,et al.  Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α. , 2015, Circulation.

[19]  T. Yang,et al.  Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the CONFIDENCE study) , 2015, Journal of internal medicine.

[20]  Y. Bao,et al.  Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[21]  Yongzhang,et al.  Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor α , 2015 .

[22]  J. Weng,et al.  SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis , 2014, Diabetes.

[23]  L. Geiss,et al.  Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. , 2014, JAMA.

[24]  Beiwen Zheng,et al.  Alterations of the human gut microbiome in liver cirrhosis , 2014, Nature.

[25]  J. Weng,et al.  Secondary diabetic ketoacidosis and severe hypoglycaemia in patients with established type 1 diabetes mellitus in China: a multicentre registration study , 2014, Diabetes/metabolism research and reviews.

[26]  Guang Wang,et al.  MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients , 2014, PloS one.

[27]  Xilin Yang,et al.  Different Associations of Diabetes With β-Cell Dysfunction and Insulin Resistance Among Obese and Nonobese Chinese Women With Prior Gestational Diabetes Mellitus , 2014, Diabetes Care.

[28]  G. Roglić,et al.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. , 2014, The lancet. Diabetes & endocrinology.

[29]  Zhonghua Wang,et al.  Effects of changes in health insurance reimbursement level on outpatient service utilization of rural diabetics: evidence from Jiangsu Province, China , 2014, BMC Health Services Research.

[30]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.

[31]  J. Mei,et al.  The impact of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) fasting glucose diagnostic criterion on the prevalence and outcomes of gestational diabetes mellitus in Han Chinese women , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[32]  L. Lin,et al.  IADPSG criteria for diagnosing gestational diabetes mellitus and predicting adverse pregnancy outcomes , 2014, Journal of Perinatology.

[33]  Chong-Zhi Wang,et al.  Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. , 2014, The Journal of clinical endocrinology and metabolism.

[34]  Yuan Zhang,et al.  Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling , 2014, Diabetes.

[35]  Cuilin Zhang,et al.  International Association of Diabetes and Pregnancy Study Group criteria is suitable for gestational diabetes mellitus diagnosis: further evidence from China , 2014, Chinese medical journal.

[36]  T. Mansfield,et al.  Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study. , 2014, Clinical therapeutics.

[37]  Wenying Yang,et al.  Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. , 2014, The lancet. Diabetes & endocrinology.

[38]  K. Fox,et al.  Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. , 2013, The American journal of medicine.

[39]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[40]  Rui Feng,et al.  Toward integrated and sustainable prevention against diabetes in rural China: study rationale and protocol of eCROPS , 2013, BMC Endocrine Disorders.

[41]  Shaihong Zhu,et al.  Changes in Adipokines following Laparoscopic Roux-en-Y Gastric Bypass Surgery in Chinese Individuals with Type 2 Diabetes Mellitus and BMI of 22–30 kg·m−2 , 2013, International journal of endocrinology.

[42]  S. Lai,et al.  Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease , 2013, Diabetes Care.

[43]  J. Kral,et al.  Defining and Predicting Complete Remission of Type 2 Diabetes: A Short-Term Efficacy Study of Open Gastric Bypass , 2013, Obesity Facts.

[44]  Qifu Li,et al.  Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial , 2013, PloS one.

[45]  Y. Pi,et al.  Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders , 2013, Nature.

[46]  Ruisheng Song,et al.  Central role of E 3 ubiquitin ligase MG 53 in insulin resistance and metabolic disorders , 2013 .

[47]  Jad Chaaban,et al.  The economic cost of physical inactivity in China. , 2013, Preventive medicine.

[48]  Cheng Hu,et al.  A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans , 2012, Diabetes.

[49]  Wenying Yang,et al.  Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity , 2012, PloS one.

[50]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[51]  Y. Bao,et al.  The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study. , 2012, Diabetes technology & therapeutics.

[52]  Fei Ye,et al.  Effect of Laparoscopic Roux-en-Y Gastroenterostomy with BMI < 35 kg/m2 in Type 2 Diabetes Mellitus , 2012, Obesity Surgery.

[53]  Weiqing Wang,et al.  Diabetic Ketoacidosis at Diagnosis Influences Complete Remission After Treatment With Hematopoietic Stem Cell Transplantation in Adolescents With Type 1 Diabetes , 2012, Diabetes Care.

[54]  L. Zeng,et al.  Effects of a combination of oral anti‐diabetes drugs with basal insulin therapy on β‐cell function and glycaemic control in patients with newly diagnosed type 2 diabetes , 2012, Diabetes/metabolism research and reviews.

[55]  F. Gao,et al.  Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[56]  Yanbing Li,et al.  Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment , 2012, Diabetes Care.

[57]  Katherine M Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[58]  Yong Li,et al.  Revealing a steroid receptor ligand as a unique PPARγ agonist , 2011, Cell Research.

[59]  Li Yang,et al.  Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[60]  G. Ning,et al.  [A randomized, double blind, placebo-controlled, parallel and multicenter study to evaluate the safety and efficacy of pioglitazone with sulphonylurea in type 2 diabetic patients]. , 2011, Zhonghua nei ke za zhi.

[61]  Weiqing Wang,et al.  A Genome-Wide Association Study Confirms Previously Reported Loci for Type 2 Diabetes in Han Chinese , 2011, PloS one.

[62]  Peter C. Austin,et al.  Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk , 2011, Diabetes Care.

[63]  J. Tuomilehto,et al.  Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008 , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[64]  Weiqing Wang,et al.  Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[65]  J. Weng,et al.  Insight into the biochemical characteristics of a novel glucokinase gene mutation , 2011, Human Genetics.

[66]  J. Zhang,et al.  Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study , 2011, Diabetologia.

[67]  Y. Le,et al.  Regulation of Fasting Fuel Metabolism by Toll-Like Receptor 4 , 2010, Diabetes.

[68]  Biao Xu,et al.  Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China , 2010, BMC health services research.

[69]  S. Dagogo-Jack.  Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum , 2010, Nature Reviews Endocrinology.

[70]  K. Xiang,et al.  Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey , 2010, BMJ : British Medical Journal.

[71]  J. Chen,et al.  Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. , 2010, Talanta.

[72]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[73]  Wei-Jia Kong,et al.  Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. , 2010, Metabolism: clinical and experimental.

[74]  V. Basevi.  Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[75]  Wenying Yang,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[76]  Wen Xu,et al.  Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study. , 2009, Chinese medical journal.

[77]  Y. Hu,et al.  Risk factors for gestational diabetes mellitus in Chinese women—a prospective study of 16 286 pregnant women in China , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[78]  Biao Xu,et al.  How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[79]  Wen Chen,et al.  Are services delivered by community health centers more cost-effective? Evidence from urban China. , 2009, Health economics.

[80]  A. Green,et al.  Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study , 2009, The Lancet.

[81]  Guoliang Cui,et al.  Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes , 2009, Cell Research.

[82]  Weiqing Wang,et al.  Reference Values for Continuous Glucose Monitoring in Chinese Subjects , 2009, Diabetes Care.

[83]  D. Friedman,et al.  Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. , 2009, Ophthalmology.

[84]  Jiuhong Kang,et al.  Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance , 2009, Nature.

[85]  R. Qian,et al.  MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATS , 2009, Clinical and experimental pharmacology & physiology.

[86]  Jing Li,et al.  The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model , 2009, Experimental diabetes research.

[87]  J. Lin,et al.  From Type 1, through LADA, to Type 2 Diabetes: A Continuous Spectrum? , 2008, Annals of the New York Academy of Sciences.

[88]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[89]  F. Hu,et al.  Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population , 2008, Diabetes.

[90]  Xian Wang,et al.  Peroxisome proliferator‐activated receptor‐δ induces insulin‐induced gene‐1 and suppresses hepatic lipogenesis in obese diabetic mice , 2008, Hepatology.

[91]  J. Jonas,et al.  Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006 , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[92]  G. Ning,et al.  Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.

[93]  H. Tian,et al.  Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial , 2008, The Lancet.

[94]  Bo Zhang,et al.  The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study , 2008, The Lancet.

[95]  Jianping Ye,et al.  Efficacy of berberine in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[96]  Linuo Zhou,et al.  High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. , 2008, Journal of diabetes and its complications.

[97]  Z Yang,et al.  Economic burden of obesity‐related chronic diseases in Mainland China , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[98]  Z. Meng,et al.  Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest , 2008, Diabetologia.

[99]  Linuo Zhou,et al.  Performance and comparison of the Cockcroft–Gault and simplified Modification of Diet in Renal Disease formulae in estimating glomerular filtration rate in a Chinese Type 2 diabetic population , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[100]  Aibin He,et al.  Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. , 2007, Molecular endocrinology.

[101]  Weiping Jia,et al.  A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family , 2007, Molecular and Cellular Biochemistry.

[102]  S. Dharmage,et al.  HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review , 2007 .

[103]  H. Deng,et al.  In vitro derivation of functional insulin-producing cells from human embryonic stem cells , 2007, Cell Research.

[104]  Yiming Li,et al.  High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. , 2007, Diabetes research and clinical practice.

[105]  S. Dharmage,et al.  HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[106]  Wei Wei,et al.  Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. , 2006, Journal of ethnopharmacology.

[107]  Yuebo Zhang,et al.  Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway , 2006 .

[108]  K. Xiang,et al.  Identification of four novel mutations in the HNF-1A gene in Chinese early-onset and/or multiplex diabetes pedigrees. , 2006, Chinese medical journal.

[109]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[110]  Roberta Bronson Fitzpatrick,et al.  Essential Science IndicatorsSM , 2005 .

[111]  F. Tang,et al.  Inducing Embryonic Stem Cells to Differentiate into Pancreatic β Cells by a Novel Three‐Step Approach with Activin A and All‐Trans Retinoic Acid , 2005, Stem cells.

[112]  V. Chan,et al.  Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients , 2005, European Journal of Human Genetics.

[113]  Roberta Bronson Fitzpatrick,et al.  Essential Science Indicators. , 2005, Medical reference services quarterly.

[114]  K. Xiang,et al.  Scanning for MODY5 gene mutations in Chinese early onset or multiple affected diabetes pedigrees , 2004, Acta Diabetologica.

[115]  J. Weng,et al.  Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. , 2004, Diabetes care.

[116]  F. Lu,et al.  Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. , 2004, Acta pharmacologica Sinica.

[117]  K. Xiang,et al.  Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. , 2004, Diabetes.

[118]  K. Reynolds,et al.  Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA) , 2003, Diabetologia.

[119]  K. Xiang,et al.  Genome-Wide Search for Type 2 Diabetes / Impaired Glucose Homeostasis Susceptibility Genes in the Chinese Significant Linkage to Chromosome 6 q 21-q 23 and Chromosome 1 q 21-q 24 , 2003 .

[120]  M. Luo,et al.  A genome-wide search for Type II diabetes susceptibility genes in Chinese Hans , 2001, Diabetologia.

[121]  R. LaPorte,et al.  Childhood Diabetes in China: Enormous variation by place and ethnic group , 1998, Diabetes Care.

[122]  X. Pan,et al.  Prevalence of Diabetes and Its Risk Factors in China, 1994 , 1997, Diabetes Care.

[123]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[124]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[125]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[126]  Zhong Xl.  Diabetes mellitus survey in China. , 1982 .

[127]  X. Zhong.  Diabetes mellitus survey in China. , 1982, Chinese medical journal.

[128]  Dang Qing,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .